{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:04:36Z","timestamp":1792037076091,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107954","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T20:59:35Z","timestamp":1731704375000},"page":"107954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of new 4-aminoquinoline derivatives containing an amine or hydroxamic acid terminal as multifunctional agents for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"153","author":[{"given":"Bochao","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107954_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114464","article-title":"Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress","volume":"238","author":"Sang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115288","article-title":"Synthesis and anti-Alzheimer potential of novel alpha-amino phosphonate derivatives and probing their molecular interaction mechanism with acetylcholinesterase","volume":"253","author":"Yelamanda Rao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106322","article-title":"New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation","volume":"131","author":"Kilic","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1206572","article-title":"Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks","volume":"15","author":"Peng","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bioorg.2024.107954_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113783","article-title":"Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT(6) receptor with anti-aggregation properties against amyloid-beta and tau","volume":"225","author":"Wichur","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107954_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107355","article-title":"Design, synthesis, in vitro and in silico evaluations of new isatin-triazine-aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds","volume":"147","author":"Tamaddon-Abibigloo","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106224","article-title":"Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation","volume":"130","author":"Zhong","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2024.107954_b0050","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1039\/C4OB00998C","article-title":"New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol","volume":"12","author":"Mao","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejmech.2019.05.051","article-title":"Development of the \u201chidden\u201d multifunctional agents for Alzheimer's disease","volume":"177","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107954_b0060","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/ph15060688","article-title":"Design, synthesis, and in vitro evaluation of novel 8-amino-quinoline combined with natural antioxidant acids","volume":"15","author":"Bacci","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107954_b0065","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1080\/14756366.2022.2122054","article-title":"Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities","volume":"37","author":"Chrienova","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107954_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200080","article-title":"Conjugates of tacrine with salicylamide as promising multitarget agents for Alzheimer's disease","volume":"17","author":"Grishchenko","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107954_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107026","article-title":"Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"143","author":"Long","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107954_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11030-021-10248-w","article-title":"Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease","volume":"26","author":"Rastegari","year":"2022","journal-title":"Mol. Divers."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107954_b0085","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1021\/acs.jmedchem.1c02150","article-title":"Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble epoxide hydrolase and acetylcholinesterase for the treatment of Alzheimer's disease","volume":"65","author":"Codony","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106465","article-title":"Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies","volume":"134","author":"Jing","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128100","article-title":"Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment","volume":"43","author":"Mezeiova","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107954_b0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acs.jmedchem.0c01775","article-title":"Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates Alzheimer-like pathology in old APP\/PS1 mice","volume":"64","author":"Viayna","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113779","article-title":"From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects","volume":"225","author":"Pont","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103328","article-title":"New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease","volume":"93","author":"Cai","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107954_b0115","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2158822","article-title":"New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease","volume":"38","author":"Czarnecka","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136222","article-title":"Dictamnine derivatives as a novel family of dual inhibitors for cholinesterase and \u03b2-amyloid aggregation","volume":"1293","author":"Zhao","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107954_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115190","article-title":"Synthesis, in vitro and in vivo biological evaluation of novel graveolinine derivatives as potential anti-Alzheimer agents","volume":"28","author":"Luo","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112193","article-title":"Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease","volume":"192","author":"Tseng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114216","article-title":"A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives","volume":"233","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106980","article-title":"Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"143","author":"Xia","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114630","article-title":"A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator","volume":"242","author":"Guo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2024.107954_b0150","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1002\/slct.201902042","article-title":"Synthesis of indoline\u2010based benzhydroxamic acids as potential HDAC6 inhibitors","volume":"4","author":"Depetter","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2024.107954_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103721","article-title":"Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation","volume":"98","author":"Xu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117178","article-title":"Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC\/AChE inhibitors for Alzheimer's disease","volume":"80","author":"Qin","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107954_b0165","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11030-019-10012-1","article-title":"Synthesis and biological evaluation of 2-phenyl-4-aminoquinolines as potential antifungal agents","volume":"24","author":"Yang","year":"2020","journal-title":"Mol. Divers."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107954_b0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107954_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106704","article-title":"1,2,3-Triazolo[4,5-b]aminoquinolines: Design, synthesis, structure, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, and molecular docking of novel modified tacrines","volume":"139","author":"Kappenberg","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115695","article-title":"Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT(6)R ligands with noticeable action on AChE\/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease","volume":"259","author":"Czarnota-Lydka","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114689","article-title":"Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease","volume":"242","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107954_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128877","article-title":"Synthesis and biological evaluation of new 2-substituted 4-amino-quinolines and -quinazoline as potential antifungal agents","volume":"72","author":"Qin","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107954_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115842","article-title":"Natural phytoalexins inspired the discovery of new biphenyls as potent antifungal agents for treatment of invasive fungal infections","volume":"261","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107954_b0205","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.bioorg.2024.107954_b0210","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:29:18Z","timestamp":1738204158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":42,"alternative-id":["S0045206824008599"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107954","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new 4-aminoquinoline derivatives containing an amine or hydroxamic acid terminal as multifunctional agents for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107954"}}